OmegaQuant Awarded NIH Grant to Investigate Fatty Acid Biomarkers for AMD and Glaucoma
Although established risk factors—such as smoking, high blood pressure, obesity, high cholesterol, cardiovascular disease, diabetes,...
Useful takeaways from this story.
Although established risk factors—such as smoking, high blood pressure, obesity, high cholesterol, cardiovascular disease, diabetes,...
OmegaQuant Analytics (Sioux Falls, SD) has been awarded an NIH Phase I Small Business Innovation Research (SBIR) grant to investigate whether patterns of fatty acids in the blood can help predict future...
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Although established risk factors—such as smoking, high blood pressure, obesity, high cholesterol, cardiovascular disease, diabetes,... OmegaQuant Analytics (Sioux Falls, SD) has been awarded an NIH Phase I Small Business Innovation Research (SBIR) grant to investigate whether patterns of fatty acids in the blood can help predict future risk of age-related macular degeneration (AMD) and glaucoma.
How it works
- OmegaQuant Analytics (Sioux Falls, SD) has been awarded an NIH Phase I Small Business Innovation Research (SBIR) grant to investigate whether patterns of fatty acids in the blood can help predict future...
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.